After orthopedic surgery, what finding is a priority to report for a patient receiving IV ketorolac?

In the context of a patient receiving IV ketorolac after orthopedic surgery, prioritizing the reporting of oliguria is crucial due to the potential renal implications associated with ketorolac use. Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) known for its analgesic properties; however, it may affect renal function, especially in individuals who are at risk. Oliguria, which is defined as a decrease in urine output, indicates possible acute kidney injury or other renal complications, especially in a postoperative setting where fluid balance can already be precarious.

Recognizing oliguria as a priority finding is important because it can signal a significant underlying issue that may require immediate medical intervention. Addressing renal issues early is essential to prevent further complications such as fluid overload, electrolyte imbalances, or exacerbation of renal dysfunction.

While other findings such as nausea, fever, or increased heart rate can indicate important issues, they do not carry the same immediate and potentially severe implications for renal function in the context of ketorolac administration, making oliguria the most critical finding to communicate to the healthcare team.